Comments

Verastem Stock Price, Quotes and Forecasts

Q: What sector and industry does Verastem (VSTM) operate in?

Verastem is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

VSTMNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Verastem (VSTM) Forecast

News Earnings Verastem (VSTM) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Verastem Stock Price, Quotes and Forecasts | NASDAQ:VSTM | Benzinga

Explore Verastem stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for VSTM.

Open	$6.30
Close	-
Volume / Avg.	886.06K / 1.58M
Day Range	$6.18 - $6.62
52 Wk Range	2.10 - 9.10
Market Cap	$341.23M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	24.28%
Days to Cover	7.52

Recent News

Nasdaq Edges Higher; ISM Manufacturing PMI Falls In May

Avi Kapoor

What's Going On With Verastem Oncology Stock On Monday?

Verastem's GFH375 trial data at ASCO 2025 shows a 52% response rate in pancreatic cancer and no dose-limiting toxicities across tested doses.

Vandana Singh

FDA Grants Accelerated Approval To Verastem's Combination Drug For Ovarian Cancer

FDA grants accelerated approval to Verastem's Avmapki Fakzynja for KRAS-mutated ovarian cancer; company plans $75 million funding for future developments.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

Jan

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$6.30
Close	-
Volume / Avg.	886.06K / 1.58M
Day Range	$6.18 - $6.62
52 Wk Range	2.10 - 9.10
Market Cap	$341.23M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	24.28%
Days to Cover	7.52

About Verastem Inc

Sector

Health Care

Industry

Biotechnology

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicin...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Verastem (VSTM) stock?

You can purchase shares of Verastem (NASDAQ:VSTM) through any online brokerage.

View our list of the best stock brokerages

Who are Verastem (VSTM) competitors?

Other companies in Verastem’s space includes: CytomX Therapeutics (NASDAQ:CTMX), Tango Therapeutics (NASDAQ:TNGX), Neurogene (NASDAQ:NGNE), Abeona Therapeutics (NASDAQ:ABEO) and Emergent BioSolutions (NYSE:EBS).

What is the forecast, or price target, for Verastem (VSTM) stock?

Verastem has a consensus price target of $15.91.

What is the current price for Verastem (VSTM)?

The stock price for Verastem (NASDAQ: VSTM) is $6.21 last updated June 6, 2025 at 9:20 AM EDT.

Does Verastem (VSTM) pay a dividend?

There are no upcoming dividends for Verastem.

When is Verastem (NASDAQ:VSTM) reporting earnings?

Verastem’s Q2 earnings are confirmed for Thursday, August 7, 2025.

Is Verastem (VSTM) going to split?

There is no upcoming split for Verastem.

What sector and industry does Verastem (VSTM) operate in?

Verastem is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.